GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » EPS (Diluted)

Pharmagreen Biotech (Pharmagreen Biotech) EPS (Diluted) : $0.00 (TTM As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech EPS (Diluted)?

Pharmagreen Biotech's Earnings per Share (Diluted) for the three months ended in Jun. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

Pharmagreen Biotech's EPS (Basic) for the three months ended in Jun. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

Pharmagreen Biotech's EPS without NRI for the three months ended in Jun. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Pharmagreen Biotech EPS (Diluted) Historical Data

The historical data trend for Pharmagreen Biotech's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech EPS (Diluted) Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
EPS (Diluted)
Get a 7-Day Free Trial -0.04 -0.01 -0.03 -0.02 -

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharmagreen Biotech's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmagreen Biotech's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's PE Ratio falls into.



Pharmagreen Biotech EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Pharmagreen Biotech's Diluted EPS for the fiscal year that ended in Sep. 2022 is calculated as

Diluted EPS (A: Sep. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.875-0)/403.733
=-0.00

Pharmagreen Biotech's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.163-0)/445.095
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmagreen Biotech  (OTCPK:PHBI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pharmagreen Biotech EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.

Pharmagreen Biotech (Pharmagreen Biotech) Headlines

From GuruFocus

PHBI Pharmgreen Launches Online Sales for Its MaxGenomic� Supplement Product

By Stock market mentor Stock market mentor 02-08-2023

PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market

By GuruFocusNews GuruFocusNews 12-21-2021